×

Starting in April, watch “The Mondays of INES“ hosted by 15 digital health experts

Find out here
Invivox
|

Replay - Overview of new 2021 ATS Clinical Practice Guidelines: Use of Fractional Exhaled Nitric Oxide (FeNO) to Guide the Treatment of Asthma

Online
Replay
177 reviews
Vyaire Medical

Vyaire Medical

See more
  • Pulmonology
  • 1h
  • English

Training details

Asthma is a heterogenous disease. Treatment decisions are typically based on measures of airflow obstruction, the frequency of daytime and nighttime symptoms, and the frequency of exacerbations. FeNO is an objective biomarker of allergic airway inflammation, an indicator of asthma and other pulmonary conditions. The new ATS Clinical Practice Guidelines provide evidence-based clinical guidance on whether FeNO testing is indicated to optimize asthma treatment in patients with asthma in whom treatment is being considered. During this webinar, Dr. Philip Silkoff, will review, which questions about FeNO where considered by the ATS committee, the principal findings of the data review and the implication of FeNO testing for the asthma care.

Educational methods

E-learning course

Units

Pheno

  • 1 h

Review

Global review

4.4 / 5

Pedagogy

4.4 / 5

Organization

4.5 / 5

Knowledge acquired

4.2 / 5

Recommandation

4.4 / 5

28/02/2023

Lindsay Z.

Excellent, thank you very much

16/06/2022

Jessique K.

22/05/2022

Krista T.

The sound was not always good. (I don't know if it was caused by my computer or by your system)

19/05/2022

Monique W.

18/05/2022

Kevin H.

18/05/2022

Sarel v.